Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of dexmedetomidine alone with dexmedetomidine and fentanyl during awake fiberoptic intubation in patients with difficult airway: a randomized clinical trial

  • Acharya, Ranjita (Department of Anesthesia and Critical Care, Siksha O Anusandhan University Institute of Medical Sciences and SUM Hospital) ;
  • Sriramka, Bhavna (Department of Anesthesia and Critical Care, Siksha O Anusandhan University Institute of Medical Sciences and SUM Hospital) ;
  • Koushik, Priyangshu (Department of Anesthesia and Critical Care, Siksha O Anusandhan University Institute of Medical Sciences and SUM Hospital)
  • Received : 2022.07.14
  • Accepted : 2022.09.05
  • Published : 2022.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Awake fiberoptic intubation (AFOI) is the procedure of choice for securing the airway in patients with a difficult airway when undergoing surgeries under general anesthesia. An ideal drug would not only provide conscious sedation but also maintain spontaneous ventilation, smooth intubation conditions, and stable hemodynamics. We compared the effects of dexmedetomidine alone and dexmedetomidine in combination with fentanyl at a dose lower than the standard dose for achieving conscious sedation during AFOI in difficult airway patients undergoing oral cancer and dental surgeries. Methods: We included 68 adult patients undergoing AFOI. The patients were randomized in two groups, wherein Group D received intravenous dexmedetomidine 1 ㎍/kg and Group DF received dexmedetomidine 0.5 ㎍/kg and fentanyl 1 ㎍/kg. The outcomes measured were airway obstruction score, intubation scores, fiberoptic intubation comfort score, sedation score, and hemodynamic variables. Results: Low-dose dexmedetomidine with fentanyl showed similar results as those with the standard dose of dexmedetomidine in terms of airway obstruction, vocal cord movement, degree of cough, degree of limb movements, and intubation comfort. However, the sedation achieved and incidence of hypotension and bradycardia were higher in Group D than in Group DF. Conclusions: A low dose of dexmedetomidine-fentanyl provides satisfactory intubation conditions as those with a standard dose of dexmedetomidine in AFOI, thereby avoiding bradycardia, hypotension, and sedation.

Keywords

References

  1. Johnston KD, Rai MR. Conscious sedation for awake fibreoptic intubation: a review of the literature. Can J Anaesth 2013; 60: 584-99. https://doi.org/10.1007/s12630-013-9915-9
  2. Stoeckel H, Schuttler J, Magnussen H, Hengstmann JH. Plasma fentanyl concentrations and the occurrence of respiratory depression in volunteers. Br J Anaesth 1982; 54: 1087-95. https://doi.org/10.1093/bja/54.10.1087
  3. Mildh L, Taittonen M, Leino K, Kirvela O. The effect of low-dose ketamine on fentanyl-induced respiratory depression. Anaesthesia 1998; 53: 965-70. https://doi.org/10.1046/j.1365-2044.1998.00519.x
  4. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 2009; 108: 852-7. https://doi.org/10.1213/ane.0b013e318184eb31
  5. Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73: 826-30. https://doi.org/10.1097/00000542-199011000-00005
  6. Alfieri A, Passavanti MB, Franco S Di, Sansone P, Vosa P, Coppolino F, et al. Dexmedetomidine in the Management of Awake Fiberoptic Intubation. Open Anesth J 2019; 13: 1-5. https://doi.org/10.2174/2589645801913010001
  7. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001; 14: 13-21.
  8. Hassan ME, Mahran E. Evaluation of different doses of dexmedetomidine alone versus the combination of dexmedetomidine and fentanyl in sedation during awake fiberoptic intubation in oral cancer surgery patients: a prospective, randomized, double-blind clinical trial. Saudi J Anaesth 2017; 11: 196-202. https://doi.org/10.4103/1658-354X.203013
  9. Liu HH, Zhou T, Wei JQ, Ma WH. Comparison between remifentanil and dexmedetomidine for sedation during modified awake fiberoptic intubation. Exp Ther Med 2015; 9: 1259-64. https://doi.org/10.3892/etm.2015.2288
  10. Mondal S, Ghosh S, Bhattacharya S, Choudhury B, Mallick S, Prasad A. Comparison between dexmedetomidine and fentanyl on intubation conditions during awake fiberoptic bronchoscopy: a randomized double-blind prospective study. J Anaesthesiol Clin Pharmacol 2015; 31: 212-6. https://doi.org/10.4103/0970-9185.155151
  11. Cabrini L, Baiardo Redaelli M, Ball L, Filippini M, Fominskiy E, Pintaudi M, et al. Awake fiberoptic intubation protocols in the operating room for anticipated difficult airway: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg 2019; 128: 971-80. https://doi.org/10.1213/ane.0000000000004087
  12. A randomized controlled study comparing dexmedetomidine-midazolam with fentanyl-midazolam for sedation during awake fiberoptic intubation in anticipated difficult airway. Anesth Essays Res 2020; 14: 271-6. https://doi.org/10.4103/aer.AER_44_20
  13. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. Eur J Anaesthesiol 2010; 27: 36-40.
  14. Adachi YU, Suzuki K, Obata Y, Doi M, Sato S. Is the hemodynamic response to nasotracheal fiberoptic bronchoscopy less than that following orotracheal bronchoscopy? Anesth Analg 2007; 105: 543-4. https://doi.org/10.1213/01.ane.0000265696.16017.c5
  15. Sharma J, Purohit S, Bhatia S, Kalra P, Sharma M, Meena R. Awake orotracheal fibre-optic intubation: comparison of two different doses of dexmedetomidine on intubation conditions in patients undergoing cervical spine surgery. Indian J Anaesth 2017; 61: 811-7. https://doi.org/10.4103/ija.IJA_169_17
  16. Nebulisation versus spray-as-you-go airway topical anaesthesia in patients with temporomandibular joint ankylosis using 2% lignocaine. J Maxillofac Oral Surg 2015; 14: 398-402. https://doi.org/10.1007/s12663-013-0613-5
  17. Xue FS, Liu HP, He N, Xu YC, Yang QY, Liao X, et al. Spray-as-you-go airway topical anesthesia in patients with a difficult airway: a randomized, double-blind comparison of 2% and 4% lidocaine. Anesth Analg 2009; 108: 536-43 https://doi.org/10.1213/ane.0b013e31818f1665